seed
Stage
2019
Founded
1
Investors
About
Liposphere develops innovative drug delivery systems based on proprietary lipid nanoparticles (LNPs) for nucleic acid therapeutics like mRNA and siRNA. Their platform enables targeted and efficient delivery, addressing unmet medical needs in various therapeutic areas.
Explore Liposphere's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.